Terms: = Pancreatic cancer AND AXIN2, AXIL, 8313, ENSG00000168646, MGC126582, DKFZp781B0869 AND Treatment
7 results:
1. Hypoxia mediates immune escape of pancreatic cancer cells by affecting miR-1275/axin2 in natural killer cells.
Ou Z; Lu Y; Xu D; Luo Z
Front Immunol; 2023; 14():1271603. PubMed ID: 38035113
[TBL] [Abstract] [Full Text] [Related]
2. pancreatic stellate cell-derived exosomal tRF-19-PNR8YPJZ promotes proliferation and mobility of pancreatic cancer through axin2.
Cao W; Dai S; Ruan W; Long T; Zeng Z; Lei S
J Cell Mol Med; 2023 Sep; 27(17):2533-2546. PubMed ID: 37488774
[TBL] [Abstract] [Full Text] [Related]
3. Tumor-derived exosomal long noncoding RNA LINC01133, regulated by Periostin, contributes to pancreatic ductal adenocarcinoma epithelial-mesenchymal transition through the Wnt/β-catenin pathway by silencing axin2.
Liu Y; Tang T; Yang X; Qin P; Wang P; Zhang H; Bai M; Wu R; Li F
Oncogene; 2021 Apr; 40(17):3164-3179. PubMed ID: 33824474
[TBL] [Abstract] [Full Text] [Related]
4. TM4SF1, a binding protein of DVL2 in hepatocellular carcinoma, positively regulates beta-catenin/TCF signalling.
Zhu C; Luo X; Wu J; Liu Y; Liu L; Ma S; Xie R; Wang S; Ji W
J Cell Mol Med; 2021 Mar; 25(5):2356-2364. PubMed ID: 31876386
[TBL] [Abstract] [Full Text] [Related]
5. Multi‑layered prevention and treatment of chronic inflammation, organ fibrosis and cancer associated with canonical WNT/β‑catenin signaling activation (Review).
Katoh M
Int J Mol Med; 2018 Aug; 42(2):713-725. PubMed ID: 29786110
[TBL] [Abstract] [Full Text] [Related]
6. Deregulation of Wnt/β-catenin signaling through genetic or epigenetic alterations in human neuroendocrine tumors.
Kim JT; Li J; Jang ER; Gulhati P; Rychahou PG; Napier DL; Wang C; Weiss HL; Lee EY; Anthony L; Townsend CM; Liu C; Evers BM
Carcinogenesis; 2013 May; 34(5):953-61. PubMed ID: 23354304
[TBL] [Abstract] [Full Text] [Related]
7. GSK3beta and beta-catenin modulate radiation cytotoxicity in pancreatic cancer.
Watson RL; Spalding AC; Zielske SP; Morgan M; Kim AC; Bommer GT; Eldar-Finkelman H; Giordano T; Fearon ER; Hammer GD; Lawrence TS; Ben-Josef E
Neoplasia; 2010 May; 12(5):357-65. PubMed ID: 20454507
[TBL] [Abstract] [Full Text] [Related]